No registrations found.
ID
Source
Brief title
Health condition
possible mechanism for cardiac lipid accumulation in obesity is studied in healthy lean mean.
Sponsors and support
Intervention
Outcome measures
Primary outcome
Cardiac lipid content after high or low free fatty acid condition.
Secondary outcome
Cardiac function (by MRI) and cardiac energy status (determined by 31P-MRS).
Background summary
To test whether the myocardium is storing more lipids when free fatty acid concentration is elevated, subjects cycled for two hours in the fasted state, which is well known to lead to an increase in free fatty acid concentrations. When subjects stay fasted during recovery, free fatty acid concentration stay high. However, when glucose drinks are administered before and during the test day, the elevation of free fatty acids is completely blunted. In the two conditions (high vs low levels of free fatty acids), cardiac lipid content and cardiac function is determined.
Study objective
Lipids are taken up by the heart when availability is high. High plasma concentrations of free fatty acids lead to increased lipid storage in the heart.
Study design
Cardiac lipid content is measured at the beginning of the test day, after cycling and after 3 hours of recovery. Cardiac function and energy status is only determined after recovery.
Intervention
Subjects cycled for 2 hours at 50% of the predetermined maximal work load in the fasted state and stay fasted during a three hour recovery period. This procedure is known to increase free fatty acid concentration. Before and after exercise and after recovery, cardiac lipid content is determined by Magnetic Resonance Spectroscopy. Cardiac function and energy status is determined at the end of the test day, after recovery. During the test day, blood samples are taken at multiple time points and fat- and carbohydrate oxidation is determined by indirect calorimetry. The same procedure is repeated with glucose supplementation to blunt the increase in free fatty acids. The two treatments (with/without glucose) were randomized.
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Inclusion criteria
1. Male sex;
2. Age: 18-35 years;
3. BMI: 18-25;
4. Stable dietary habits (no weight gain or loss of >8% of bodyweight in the last 6 months);
5. No medication.
Exclusion criteria
1. Known cardiovascular disease, diabetes or dyslipididemia;
2. Contra-indication for MRI (electronic implants, iron containing corpora alinea in eyes, certain hearing aids and certain artificial heart valves);
3. Weight gain/loss > 8% of body weight;
4. Medication use.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1807 |
NTR-old | NTR1917 |
Other | METC Maastricht University Medical Center : MEC 08-3-063 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |